ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,908Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 98

$738K Total Retail Price of All Prescriptions

Rank: 14 out of 98

298 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 298 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

4% of this provider’s 298 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 13,562 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

50 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,096 1,006 1 1
FUROSEMIDE 554 525 2 4
SIMVASTATIN 499 463 3 2
TRAZODONE HCL 483 459 4 9
LISINOPRIL 467 448 5 3
METOPROLOL TARTRATE 448 426 6 8
MIRTAZAPINE 427 404 7 11
LEVOTHYROXINE SODIUM 384 372 8 5
DONEPEZIL HCL 378 377 9 12
OMEPRAZOLE 366 322 10 6
AMLODIPINE BESYLATE 358 341 11 7
CITALOPRAM HBR 332 316 12 10
GABAPENTIN 274 240 13 13
SERTRALINE HCL 273 267 14 19
OLANZAPINE 269 233 15 24
DIVALPROEX SODIUM 268 234 16 22
NAMENDA 253 253 17 18
METFORMIN HCL 250 211 18 15
ATENOLOL 200 179 19 14
LIDODERM 190 176 20 29
RISPERIDONE 175 174 21 27
METOPROLOL SUCCINATE 171 171 22 16
TAMSULOSIN HCL 169 164 23 25
ATORVASTATIN CALCIUM 157 154 24 20
PRAVASTATIN SODIUM 139 139 25 41
FLUOXETINE HCL 139 111 25 48
QUETIAPINE FUMARATE 131 119 27 23
PANTOPRAZOLE SODIUM 108 108 28 42
PREDNISONE 107 99 29 31
IPRATROPIUM-ALBUTEROL 106 100 30 45
LANTUS 104 101 31 28
HYDROCHLOROTHIAZIDE 103 100 32 17
NIFEDIPINE ER 101 89 33 68
CARBIDOPA-LEVODOPA 100 100 34 44
POTASSIUM CHLORIDE 100 98 34 21
POLYETHYLENE GLYCOL 3350 100 87 34 33
ALLOPURINOL 99 99 37 43
NYSTATIN 98 66 38 56
RANITIDINE HCL 91 74 39 35
SPIRONOLACTONE 84 71 40 71
LEVETIRACETAM 84 73 40 38
ALENDRONATE SODIUM 84 84 40 30
CYMBALTA 81 68 43 47
CARVEDILOL 77 76 44 72
DIGOXIN 75 75 45 40
GLIPIZIDE 74 66 46 37
BUPROPION HCL SR 72 59 47 100
TRAMADOL HCL 71 63 48 26
ADVAIR DISKUS 71 71 48 32
NYSTOP 69 58 50 64
FINASTERIDE 68 68 51 49
CLOPIDOGREL 67 66 52 50
NOVOLIN R 66 61 53 79
ISOSORBIDE MONONITRATE ER 66 65 53 36
BACLOFEN 65 17 55 59
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 48 56 114
ERYTHROMYCIN 57 53 57 107
SPIRIVA 57 42 57 46
BUPROPION HCL 57 50 57 96
CEPHALEXIN 56 43 60 92
PAROXETINE HCL 53 50 61 73
NOVOLIN N 53 44 61 85
HYDROCODONE-ACETAMINOPHEN 52 32 S3 63 39
LEVOFLOXACIN 51 47 64 63
OXYBUTYNIN CHLORIDE ER 50 43 65 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.